11.01.2016
- Sanofi has handed back rights to the inhaled insulin treatment Afrezza to US drug development company MannKind. Sales of Afrezza, which launched in the US in February last year...
23.12.2015
- Bayer is likely to seek a major life sciences M&A deal in the next few years, banking sources have told the news agency Reuters. The German group’s absence from a recent wave of...
16.12.2015
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of...
15.12.2015
- Mexico has granted marketing authorization to Sanofi Pasteur for its dengue vaccine, Dengvaxia. The vaccine is the world’s first to be approved for preventing the disease which is...
30.11.2015
- Drugs firms AstraZeneca and Sanofi are to exchange 210,000 compounds from their libraries to help boost their search for new small-molecule medicines. The companies have selected...
16.11.2015
- Mylan’s seven month-long, $26 billion long-shot hostile bid for Perrigo has ended in defeat for the Netherlands-based drugmaker. By the target deadline of Friday, Nov. 13, only 40%...
13.11.2015
- French drugmaker Sanofi has entered into two separate collaborations to develop and commercialize diabetes treatments. An agreement with US-based Lexicon Pharmaceuticals centers on...
12.11.2015
- French drugmaker Sanofi has announced a new long-term strategy focused on four pillars including a reshaping of its portfolio, new drug launches, innovation in R&D and a...
12.11.2015
- DuPont Industrial Biosciences is paying $75 million to acquire the enzyme and technology assets of Dyadic, a financially struggling US biotech firm based at Jupiter, Florida. The...
09.11.2015
- When looking for a location to invest in a production facility, a research center or an office building, companies need to consider numerous factors. There is an increasing...
